Delivery Order SPE2DR25D3801-SPE2DR26F6QBR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with a ceiling value of $4,021.65 and an ultimate completion date of October 10, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,574.80 on September 15, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,893.49 to AmerisourceBergen Drug Corp for the supply of Botox Cosmetic 100 Unit Vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 23, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was competed among all qualified vendors in the open market. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.88 to AmerisourceBergen Drug Corp for the supply of Botox Cosmetic 100 Unit Vials under contract 4570309502. This firm fixed-price delivery order, awarded on December 16, 2025, with an ultimate completion date of January 8, 2026, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a $6,560 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials with a completion date of June 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX Cosmetic under a firm fixed-price contract valued at $1,787.40. The award, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of BOTOX Cosmetic 100-unit vials with a ceiling value of $1,787.40. This firm fixed-price delivery order, which is expected to be completed by October 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract was competitively awarded without set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $6,702.75 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for Botox Cosmetic 100 Unit Vials with an ultimate completion date of September 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.88 to AmerisourceBergen Drug Corp for the supply of Botox Cosmetic 100 unit vials. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract contains no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3801Indefinite Delivery Contract
- SPE2DR25D3801-SPE2DR26F6QBRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with a ceiling value of $1,297.83 and an ultimate completion date of December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates significant capacity in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order represents a routine fulfillment under the broader pharmaceutical support vehicle, enabling the company to meet medical supply needs for military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/23/25 |